Connect with us

Health

EU missing out on the benefits of early HIV and hepatitis diagnosis

SHARE:

Published

7 months ago

on

We use your sign-up to provide content in ways you've consented to and to improve our understanding of you. You can unsubscribe at any time.

A new ECDC monitoring report shows that many EU/EEA countries are still not achieving the full benefits of early diagnosis for HIV, hepatitis B and hepatitis C.

In the latest monitoring report on HIV, hepatitis B (HBV) and hepatitis C (HCV) the ECDC reported that 27 countries have national HIV-testing policies, while 22 have recommendations on hepatitis B and C, only 17 have the ECDC’s preferred option of integrated testing for all three and sexually transmitted diseases... 

To read the complete article, click here.

Share this article:

Share this:
Related Topics:
Guest Contributor - Opinion

Opinions expressed are purely those of the author and not endorsed by EU Reporter. The article was unsolicited by EU Reporter, and the author guarantees the truthfulness of the contents of the article. No payment was made by EU Reporter to the author

EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.
Advertisement

Trending